Peer Reviewed Cancer
Released: March 9, 2016
Defense Health Program
Department of Defense Peer Reviewed Cancer Research Program
Funding Opportunities for Fiscal Year 2016 (FY16)
The FY16 Defense Appropriations Act provides $50 million (M) to the Department of Defense Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/ Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
The PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY16 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in April and July 2016. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.
Congressionally Directed Topic Areas: To be considered for funding, applications for the FY16 PRCRP must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted.
The FY16 PRCRP Topic Areas are listed below:
|Bladder cancer (New for FY16)||Liver cancer||Pancreatic cancer|
|Colorectal cancer||Lymphoma (New for FY16)||Pediatric Brain Tumors (New for FY16)|
|Immunotherapy* (New for FY16)||Melanoma and other skin cancers||Stomach cancer|
|Listeria vaccine for cancer||Neuroblastoma|
The FY16 PRCRP Military Relevance Focus Areas are listed below:
To address the cancer health needs of both deployed and non-deployed personnel, their dependents, retirees, and Veterans, the FY16 PRCRP seeks to support studies that are responsive to the Military Relevance Focus Areas listed below:
- Militarily relevant risk factors associated with cancer (e.g., ionizing radiation, chemicals, infectious agents, and environmental carcinogens)
- Gaps in cancer prevention, screening, early detection, diagnosis, treatment, and/or survivorship that may affect the general population but have a particularly profound impact on the health and well-being of military members, Veterans, and their beneficiaries
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Career Development Award||Principal Investigator (PI): Independent early-career investigator within 10 years after completion of his/her terminal degree (excluding time spent in residency or on family medical leave) by the time of the application submission deadline.
Designated Mentor: Investigators at or above the level of Associate Professor (or equivalent); must have a proven publication and funding record in cancer research.
|Idea Award with Special Focus||Investigator with a faculty-level appointment (or equivalent).||
|Translational Team Science Award||
At least two and up to three PIs must partner in one overarching correlative or translational research study.
At least one of the PIs is encouraged to be a military or Department of Veterans Affairs investigator.
|Horizon Award (to be released at a later date)||
PI: A predoctoral candidate within two years of successfully passing qualifying examinations or a postdoctoral fellow within three years of completion of his/her terminal degree (excluding medical residency or family medical leave).
Mentor: The Mentor must be an experienced cancer researcher as demonstrated by a strong record of funding and publications. In addition, the Mentor must demonstrate a commitment to advancing the PI's career in cancer research.
The PI and the Mentor must be at the same organization.
A pre-application is required and must be submitted through the CDMRP electronic Biomedical Research Application Portal (eBRAP) website (https://eBRAP.org) prior to the pre-application deadline. All applications must conform to the final Program Announcement(s) and General Application Instructions that will be available for electronic downloading from the Grants.gov website. Applications must be submitted through the federal government's single-entry portal, Grants.gov. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission deadlines are not available until the Program Announcement(s) is released. Requests for email notification of the Program Announcement(s) release may be sent to help@eBRAP.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.
For more information about the PRCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs
Last updated Tuesday, January 4, 2022